La FDA aprueba una actualización de la ficha técnica en EEUU de donanemab
El nuevo régimen de dosificación recomendado redujo significativamente las tasas de ARIA en comparación con la pauta posológica original, reforzando
Leer másEl nuevo régimen de dosificación recomendado redujo significativamente las tasas de ARIA en comparación con la pauta posológica original, reforzando
Leer másAmbas decisiones se producen tras la aprobación acelerada de la FDA estadounidense en diciembre de 2012 y la aprobación condicional
Leer másCookie | Duración | Descripción |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |